{"id":"W4413836422","doi":"10.1158/1078-0432.ccr-24-4342","title":"Phase I Dose-Escalation Trial Combining Olaparib and Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca; AstraZeneca United States","keywords":"Medicine; Olaparib; Pneumonitis; Esophagitis; Internal medicine; PARP inhibitor; Radiation therapy; Adverse effect; Oncology; Gastroenterology; Urology; Surgery; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005613922,0.0002573305,0.000953775,0.0005930716,0.0002954515,0.000106313,0.0002865195,0.0002875585,0.0003332634],"category_scores_gemma":[0.001906965,0.0002190007,0.0001646232,0.00136738,0.0008376577,0.0001289351,0.0003264673,0.002254518,0.000005391243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001053826,"about_ca_system_score_gemma":0.002282572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002643801,"about_ca_topic_score_gemma":0.001248759,"domain_scores_codex":[0.9950418,0.001110554,0.0009754031,0.0009673249,0.0009291913,0.0009757019],"domain_scores_gemma":[0.9954979,0.002680317,0.0001235125,0.0005781371,0.0007490226,0.0003710554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2491262,0.00441818,0.4232777,0.003051891,0.0007869016,0.0003382432,0.001721779,0.00007726102,0.005919893,0.0003584032,0.0281326,0.2827909],"study_design_scores_gemma":[0.6421677,0.01113636,0.2218287,0.005483426,0.0004197026,0.000004089613,0.001739393,0.03153638,0.004648794,0.0005545475,0.07943371,0.001047182],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9470594,0.03704201,0.0001151198,0.009017634,0.0006978509,0.003530904,0.00003631414,0.00005775007,0.002443046],"genre_scores_gemma":[0.945752,0.04073765,0.0002462347,0.0009741136,0.0009505015,0.001510409,0.00001549869,0.00005463661,0.009758992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3930414,"threshold_uncertainty_score":0.9794885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2474000908450765,"score_gpt":0.6157291510270154,"score_spread":0.3683290601819389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}